Big Move For TransCode Therapeutics Inc.
Wed, Feb 05, 2025 at 07:35 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) rocketted at $8.94, a gain of 45.1%. On Wed, Feb 05, 2025, RNAZ:NASDAQ touched a New 2-Week Intraday High of $12.7. The stock appeared on our News Catalysts scanner on Fri, Jan 31, 2025 at 03:17 AM in the 'BIOTECH' category. From Thu, Jan 23, 2025, the stock recorded 33.33% Up Days and 60.00% Green Days
The stock spiked on Tue, Jan 28, 2025 at $16.73 with a volume of 37M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Invivyd Inc. (IVVD:NASDAQ), 68.8%
- Asset Entities Inc. (ASST:NASDAQ), 46.16%
- Aurora Cannabis Inc. (ACB:NASDAQ), 45.92%
- RF Acquisition Corp. (RFAC:NASDAQ), 45.67%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 45.13%
- BigBear.ai Inc. (BBAI:NYSE), 44.81%
- Cumberland Pharmaceuticals Inc. (CPIX:NASDAQ), 35.11%
- Celularity Inc. (CELU:NASDAQ), 33.17%
- Rapid Micro Biosystems Inc. (RPID:NASDAQ), 32.31%
- Zentalis Pharmaceuticals, LLC (ZNTL:NASDAQ), 31.29%